Asset Allocation

As of March 31, 2026.
Type % Net
Cash 1.48%
Stock 48.14%
Bond 34.85%
Convertible 0.00%
Preferred 8.00%
Other 7.53%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 24.57%
Mid 24.35%
Small 51.09%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 92.74%    % Emerging Markets: 2.59%    % Unidentified Markets: 4.67%

Americas 76.05%
73.03%
Canada 10.38%
United States 62.65%
3.03%
Chile 0.17%
Mexico 1.76%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 11.75%
United Kingdom 4.34%
7.41%
Belgium 0.60%
France 2.88%
Ireland 0.04%
Italy 2.71%
Spain 0.57%
Sweden 0.19%
0.00%
0.00%
Greater Asia 7.52%
Japan 1.06%
3.06%
Australia 3.06%
3.40%
Hong Kong 1.74%
Singapore 1.67%
0.00%
Unidentified Region 4.67%

Bond Credit Quality Exposure

AAA 0.25%
AA 0.61%
A 2.44%
BBB 35.76%
BB 36.29%
B 17.35%
Below B 1.25%
    CCC 1.15%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.10%
Not Rated 1.76%
Not Available 4.30%
Short Term 0.00%
As of March 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
58.59%
Materials
0.00%
Consumer Discretionary
0.00%
Financials
0.62%
Real Estate
57.97%
Sensitive
15.78%
Communication Services
2.03%
Energy
7.91%
Industrials
5.84%
Information Technology
0.00%
Defensive
22.62%
Consumer Staples
0.00%
Health Care
1.80%
Utilities
20.81%
Not Classified
3.01%
Non Classified Equity
1.87%
Not Classified - Non Equity
1.14%
As of March 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of March 31, 2026
Type % Net
Government 1.01%
Corporate 79.35%
Securitized 7.75%
Municipal 0.00%
Other 11.89%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.10%
Less than 1 Year
0.10%
Intermediate
50.35%
1 to 3 Years
4.40%
3 to 5 Years
13.66%
5 to 10 Years
32.29%
Long Term
44.73%
10 to 20 Years
6.71%
20 to 30 Years
21.15%
Over 30 Years
16.87%
Other
4.81%
As of March 31, 2026
View Bond Maturity Exposure
Start Trial